Panel will seek 'appropriate' AIDS goals for South Africa.
Cherry
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D004196:Disease Outbreaks; D006076:Government; D006801:Humans; D011640:Public Policy; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D013019:South Africa / Q000453:epidemiology; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine